WHO Receives $1 Billion Pledge, Tedros Warns
At a major event in Berlin, the World Health Organization (WHO) announced the encouraging news that it has received pledges worth $700 million to support its budget from 2025 to 2028, in addition to the $300 million already committed by the European Union and the African Union. The news was revealed during a speech by WHO Director-General Tedros Adhanom Ghebreyesus, WHO highlighted the serious challenges the COVID-19 pandemic poses to global health and security, noting that investing in WHO is not just an investment in health, It is an investment in building a more equitable, stable and secure socio-economic system.
In his remarks, Director-General Tedros noted that the COVID-19 pandemic has highlighted the importance of health issues to global security and prosperity, so support and investment in WHO is critical. He stressed that a healthy global population is the cornerstone of social and economic development, and that WHO has an integral role to play in this process.
German Chancellor Olaf Scholz, who also spoke at the event, announced that Germany would provide at least 360 million euros ($392.47 million) in financial support, noting that it would be better to spread the responsibility and burden across more countries. Prime Minister Scholz also stressed that every support, no matter how large or small, is valuable and has important significance for global health.
Two years ago, the WHO's member states agreed to a radical overhaul of the organization's funding model, which was criticized as "fundamentally rotten" because of its excessive reliance on irregular donations from donors. Under the new agreement, WHO's mandatory costs should increase from 16% in recent years to 50% of its budget by 2030-2031, which will help ensure that the organization has a more stable and predictable source of funding to better fulfill its mandate in the field of global health. This reform is essential for the long-term sustainability of WHO and for global public health security.
Looking for chemical products? Let suppliers reach out to you!
2026-07-10
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
Recommend Reading
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
February EVA Market Conditions Steadily Organized in China
-
In the Fourth Quarter, China's Phenol Market Declined Significantly, Reaching a Five-Year Low
-
Will 2026 Bring a Turnaround After DMF Prices Hit Bottom in 2025 in China?
-
China’s Acetone Market in 2025 Continues to Decline, Constantly Reaching New Lows
-
In December, the ammonium sulfate market in China showed a weak downward trend